1. Product Overview
1.1. Market Definition
1.2. Scope of the Market
1.2.1.
Markets Covered
1.2.2.
Years Considered for
Study
1.2.3.
Key Market
Segmentations
2. Research Methodology
2.1. Objective
of the Study
2.2. Baseline
Methodology
2.3. Key
Industry Partners
2.4. Major
Association and Secondary Sources
2.5. Forecasting
Methodology
2.6. Data
Triangulation & Validations
2.7. Assumptions
and Limitations
3. Executive Summary
3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends
4. Voice of Customer
5.
Global Next Generation
Biotherapeutics Market Outlook
5.1. Market Size & Forecast
5.1.1. By Value
5.2. Market Share & Forecast
5.2.1. By Therapeutic Area (Oncology, Autoimmune/ Inflammatory
Diseases)
5.2.2. By Technology (Antibody-Drug Conjugates, Bispecific
Antibodies, Antibody Fragments, Antibody-like Proteins, Others)
5.2.3. By Region
5.2.4. By Company (2022)
5.3. Market Map
6.
North America Next
Generation Biotherapeutics Market Outlook
6.1.
Market Size &
Forecast
6.1.1.
By Value
6.2.
Market Share &
Forecast
6.2.1.
By Therapeutic Area
6.2.2.
By Technology
6.2.3.
By Country
6.3. North America: Country Analysis
6.3.1. United States Next Generation Biotherapeutics
Market Outlook
6.3.1.1.
Market Size & Forecast
6.3.1.1.1.
By Value
6.3.1.2.
Market Share & Forecast
6.3.1.2.1.
By Therapeutic Area
6.3.1.2.2.
By Technology
6.3.2. Canada Next Generation Biotherapeutics
Market Outlook
6.3.2.1.
Market Size & Forecast
6.3.2.1.1.
By Value
6.3.2.2.
Market Share & Forecast
6.3.2.2.1.
By Therapeutic Area
6.3.2.2.2.
By Technology
6.3.3. Mexico Next Generation Biotherapeutics
Market Outlook
6.3.3.1.
Market Size & Forecast
6.3.3.1.1.
By Value
6.3.3.2.
Market Share & Forecast
6.3.3.2.1.
By Therapeutic Area
6.3.3.2.2.
By Technology
7.
Europe Next
Generation Biotherapeutics Market Outlook
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Therapeutic Area
7.2.2. By Technology
7.2.3. By Country
7.3. Europe: Country Analysis
7.3.1. Germany Next Generation Biotherapeutics
Market Outlook
7.3.1.1.
Market Size & Forecast
7.3.1.1.1.
By Value
7.3.1.2.
Market Share & Forecast
7.3.1.2.1.
By Therapeutic Area
7.3.1.2.2.
By Technology
7.3.2. United Kingdom Next Generation Biotherapeutics
Market Outlook
7.3.2.1.
Market Size & Forecast
7.3.2.1.1.
By Value
7.3.2.2.
Market Share & Forecast
7.3.2.2.1.
By Therapeutic Area
7.3.2.2.2.
By Technology
7.3.3. Italy Next Generation Biotherapeutics Market Outlook
7.3.3.1.
Market Size & Forecast
7.3.3.1.1.
By Value
7.3.3.2.
Market Share & Forecasty
7.3.3.2.1.
By Therapeutic Area
7.3.3.2.2.
By Technology
7.3.4. France Next Generation Biotherapeutics
Market Outlook
7.3.4.1.
Market Size & Forecast
7.3.4.1.1.
By Value
7.3.4.2.
Market Share & Forecast
7.3.4.2.1.
By Therapeutic Area
7.3.4.2.2.
By Technology
7.3.5. Spain Next Generation Biotherapeutics Market Outlook
7.3.5.1.
Market Size & Forecast
7.3.5.1.1.
By Value
7.3.5.2.
Market Share & Forecast
7.3.5.2.1.
By Therapeutic Area
7.3.5.2.2.
By Technology
8.
Asia-Pacific Next Generation
Biotherapeutics Market Outlook
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Therapeutic Area
8.2.2. By Technology
8.2.3. By Country
8.3. Asia-Pacific: Country Analysis
8.3.1. China Next Generation Biotherapeutics Market Outlook
8.3.1.1.
Market Size & Forecast
8.3.1.1.1.
By Value
8.3.1.2.
Market Share & Forecast
8.3.1.2.1.
By Therapeutic Area
8.3.1.2.2.
By Technology
8.3.2. India Next Generation Biotherapeutics Market Outlook
8.3.2.1.
Market Size & Forecast
8.3.2.1.1.
By Value
8.3.2.2.
Market Share & Forecast
8.3.2.2.1.
By Therapeutic Area
8.3.2.2.2.
By Technology
8.3.3. Japan Next Generation Biotherapeutics Market Outlook
8.3.3.1.
Market Size & Forecast
8.3.3.1.1.
By Value
8.3.3.2.
Market Share & Forecast
8.3.3.2.1.
By Therapeutic Area
8.3.3.2.2.
By Technology
8.3.4. South Korea Next Generation Biotherapeutics
Market Outlook
8.3.4.1.
Market Size & Forecast
8.3.4.1.1.
By Value
8.3.4.2.
Market Share & Forecast
8.3.4.2.1.
By Therapeutic Area
8.3.4.2.2.
By Technology
8.3.5. Australia Next Generation Biotherapeutics
Market Outlook
8.3.5.1.
Market Size & Forecast
8.3.5.1.1.
By Value
8.3.5.2.
Market Share & Forecast
8.3.5.2.1.
By Therapeutic Area
8.3.5.2.2.
By Technology
9.
South America Next
Generation Biotherapeutics Market Outlook
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Therapeutic Area
9.2.2. By Technology
9.2.3. By Country
9.3. South America: Country Analysis
9.3.1. Brazil Next Generation Biotherapeutics
Market Outlook
9.3.1.1.
Market Size & Forecast
9.3.1.1.1.
By Value
9.3.1.2.
Market Share & Forecast
9.3.1.2.1.
By Therapeutic Area
9.3.1.2.2.
By Technology
9.3.2. Argentina Next Generation Biotherapeutics
Market Outlook
9.3.2.1.
Market Size & Forecast
9.3.2.1.1.
By Value
9.3.2.2.
Market Share & Forecast
9.3.2.2.1.
By Therapeutic Area
9.3.2.2.2.
By Technology
9.3.3. Colombia Next Generation Biotherapeutics
Market Outlook
9.3.3.1.
Market Size & Forecast
9.3.3.1.1.
By Value
9.3.3.2.
Market Share & Forecast
9.3.3.2.1.
By Therapeutic Area
9.3.3.2.2.
By Technology
10.
Middle East and
Africa Next Generation Biotherapeutics Market Outlook
10.1.
Market Size &
Forecast
10.1.1. By Value
10.2.
Market Share &
Forecast
10.2.1. By Therapeutic Area
10.2.2. By Technology
10.2.3. By Country
10.3.
MEA: Country
Analysis
10.3.1. South Africa Next Generation Biotherapeutics
Market Outlook
10.3.1.1. Market Size &
Forecast
10.3.1.1.1.
By Value
10.3.1.2. Market Share &
Forecast
10.3.1.2.1.
By Therapeutic Area
10.3.1.2.2.
By Technology
10.3.2. Saudi Arabia Next Generation Biotherapeutics
Market Outlook
10.3.2.1. Market Size & Forecast
10.3.2.1.1.
By Value
10.3.2.2. Market Share &
Forecast
10.3.2.2.1.
By Therapeutic Area
10.3.2.2.2.
By Technology
10.3.3. UAE Next Generation Biotherapeutics Market Outlook
10.3.3.1. Market Size &
Forecast
10.3.3.1.1.
By Value
10.3.3.2. Market Share &
Forecast
10.3.3.2.1.
By Therapeutic Area
10.3.3.2.2.
By Technology
11. Market Dynamics
11.1.
Drivers
11.2.
Challenges
12. Market Trends & Developments
12.1.
Recent Development
12.2.
Mergers &
Acquisitions
12.3.
Product Launches
13.
Global Next Generation Biotherapeutics Market: SWOT
Analysis
14.
Porter’s Five Forces Analysis
14.1.
Competition in the
Industry
14.2.
Potential of New
Entrants
14.3.
Power of Suppliers
14.4.
Power of Customers
14.5.
Threat of Substitute
Products
15. Competitive Landscape
15.1.
Business Overview
15.2.
Service Offerings
15.3.
Recent Developments
15.4.
Key Personnel
15.5.
SWOT Analysis
15.5.1. Xencor, Inc.
15.5.2. Regenxbio & Neurimmune AG
15.5.3. Takeda Pharmaceutical Company
Limited
15.5.4. Pfizer, Inc.
15.5.5. AstraZeneca Plc.
15.5.6. F. Hoffmann-La Roche AG
15.5.7. Kyowa Kirin Co., Ltd
15.5.8. Seattle Genetics, Inc
15.5.9. ImmunoGen, Inc
15.5.10.
Ono Pharmaceuticals Co, Ltd
16.
Strategic Recommendations
About Us & Disclaimer